Elsevier Inc.

SHERPA: Unknown

People

  1. Castro-Malaspina
    Castro-Malaspina
  2. Devlin
    Devlin
  3. Giralt
    Giralt
  4. Jakubowski
    Jakubowski
  5. Papadopoulos
    Papadopoulos
  6. Perales
    Perales
  7. Ponce
    Ponce
  8. Van Den Brink
    Van Den Brink
  9. Young
    Young
  10. Casson
    Casson

Groups

  1. Center for Hematologic Malignancies (3)
  2. Department of Medicine (3)
  3. GSK Faculty (3)
  4. Immunology Program Faculty (3)
  5. Nursing (3)
  6. Sloan Kettering Institute Faculty (3)
  7. Survivorship Research (3)
  8. Advanced Practice Providers (2)
  9. Biostatistics Service (2)
  10. Bone Marrow Transplant (2)
Search Within
  1. "Meeting abstract"
  2. "Nursing"
  3. "Sloan Kettering Institute Faculty"
  4. "2016"
Formats
  1. Meeting Abstract (3)
Groups
  1. Center for Hematologic Malignancies (3)
  2. Department of Medicine (3)
  3. GSK Faculty (3)
  4. Immunology Program Faculty (3)
  5. Nursing (3)
  6. Sloan Kettering Institute Faculty (3)

More Groups

People
  1. Ann Jakubowski (2)
  2. Craig Sauter (2)
  3. Doris Ponce (2)
  4. Esperanza Papadopoulos (2)
  5. Guenther Koehne (2)
  6. Hugo Castro-Malaspina (2)

More People

Years
  1. 2016 (3)
Publications
  1. Biology of Blood and Marrow Transplantation (3)

Results (3)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CD34+ selected ex-vivo T-cell depleted (TCD) grafts for allogeneic hematopoietic cell transplantation (Allo-HSCT) is associated with low incidence of acute and chronic graft-versus-host disease (GVHD) and high chronic-GVHD/relapse-free survival
    Meeting Abstract

    Barba, P.; Hilden, P.; Devlin, S. M.; Maloy, M.; Ciolino, C.; Dierov, D.; Herman, D.; Mosesso, K.; Nieves, J.; Barker, J. N.; more...
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • T- cell depleted peripheral blood stem cell (TCD-PBSC) transplants secure consistent engraftment with low risk of acute or chronic GVHD and favorable disease free survival (DFS) and overall survival (OS) for pediatric patients (< 21 years) with AML in CR1
    Meeting Abstract

    Kernan, N. A.; Boulad, F.; Prockop, S. E.; Scaradavou, A.; Kobos, R.; Lehrman, R.; Klein, E.; Wolden, S.; Curran, K. J.; Hasan, A. N.; more...
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Low dose unfractionated heparin (UFH) prophylaxis is a feasible strategy for the prevention of hepatic sinusoidal obstruction syndrome (SOS) after myeloablative adult allogeneic hematopoietic stem cell transplantation (HSCT)
    Meeting Abstract

    Bhatt, V.; Palazzo, M.; Kilroy, K.; Hilden, P.; Devlin, S. M.; Maloy, M.; Barker, J. N.; Castro-Malaspina, H.; Chung, D. J.; Dahi, P.; more...
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save